Cargando…
Deep topographic proteomics of a human brain tumour
The spatial organisation of cellular protein expression profiles within tissue determines cellular function and is key to understanding disease pathology. To define molecular phenotypes in the spatial context of tissue, there is a need for unbiased, quantitative technology capable of mapping proteom...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673928/ https://www.ncbi.nlm.nih.gov/pubmed/38001067 http://dx.doi.org/10.1038/s41467-023-43520-8 |
_version_ | 1785149662005559296 |
---|---|
author | Davis, Simon Scott, Connor Oetjen, Janina Charles, Philip D. Kessler, Benedikt M. Ansorge, Olaf Fischer, Roman |
author_facet | Davis, Simon Scott, Connor Oetjen, Janina Charles, Philip D. Kessler, Benedikt M. Ansorge, Olaf Fischer, Roman |
author_sort | Davis, Simon |
collection | PubMed |
description | The spatial organisation of cellular protein expression profiles within tissue determines cellular function and is key to understanding disease pathology. To define molecular phenotypes in the spatial context of tissue, there is a need for unbiased, quantitative technology capable of mapping proteomes within tissue structures. Here, we present a workflow for spatially-resolved, quantitative proteomics of tissue that generates maps of protein abundance across tissue slices derived from a human atypical teratoid-rhabdoid tumour at three spatial resolutions, the highest being 40 µm, to reveal distinct abundance patterns of thousands of proteins. We employ spatially-aware algorithms that do not require prior knowledge of the fine tissue structure to detect proteins and pathways with spatial abundance patterns and correlate proteins in the context of tissue heterogeneity and cellular features such as extracellular matrix or proximity to blood vessels. We identify PYGL, ASPH and CD45 as spatial markers for tumour boundary and reveal immune response-driven, spatially-organised protein networks of the extracellular tumour matrix. Overall, we demonstrate spatially-aware deep proteo-phenotyping of tissue heterogeneity, to re-define understanding tissue biology and pathology at the molecular level. |
format | Online Article Text |
id | pubmed-10673928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106739282023-11-24 Deep topographic proteomics of a human brain tumour Davis, Simon Scott, Connor Oetjen, Janina Charles, Philip D. Kessler, Benedikt M. Ansorge, Olaf Fischer, Roman Nat Commun Article The spatial organisation of cellular protein expression profiles within tissue determines cellular function and is key to understanding disease pathology. To define molecular phenotypes in the spatial context of tissue, there is a need for unbiased, quantitative technology capable of mapping proteomes within tissue structures. Here, we present a workflow for spatially-resolved, quantitative proteomics of tissue that generates maps of protein abundance across tissue slices derived from a human atypical teratoid-rhabdoid tumour at three spatial resolutions, the highest being 40 µm, to reveal distinct abundance patterns of thousands of proteins. We employ spatially-aware algorithms that do not require prior knowledge of the fine tissue structure to detect proteins and pathways with spatial abundance patterns and correlate proteins in the context of tissue heterogeneity and cellular features such as extracellular matrix or proximity to blood vessels. We identify PYGL, ASPH and CD45 as spatial markers for tumour boundary and reveal immune response-driven, spatially-organised protein networks of the extracellular tumour matrix. Overall, we demonstrate spatially-aware deep proteo-phenotyping of tissue heterogeneity, to re-define understanding tissue biology and pathology at the molecular level. Nature Publishing Group UK 2023-11-24 /pmc/articles/PMC10673928/ /pubmed/38001067 http://dx.doi.org/10.1038/s41467-023-43520-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Davis, Simon Scott, Connor Oetjen, Janina Charles, Philip D. Kessler, Benedikt M. Ansorge, Olaf Fischer, Roman Deep topographic proteomics of a human brain tumour |
title | Deep topographic proteomics of a human brain tumour |
title_full | Deep topographic proteomics of a human brain tumour |
title_fullStr | Deep topographic proteomics of a human brain tumour |
title_full_unstemmed | Deep topographic proteomics of a human brain tumour |
title_short | Deep topographic proteomics of a human brain tumour |
title_sort | deep topographic proteomics of a human brain tumour |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673928/ https://www.ncbi.nlm.nih.gov/pubmed/38001067 http://dx.doi.org/10.1038/s41467-023-43520-8 |
work_keys_str_mv | AT davissimon deeptopographicproteomicsofahumanbraintumour AT scottconnor deeptopographicproteomicsofahumanbraintumour AT oetjenjanina deeptopographicproteomicsofahumanbraintumour AT charlesphilipd deeptopographicproteomicsofahumanbraintumour AT kesslerbenediktm deeptopographicproteomicsofahumanbraintumour AT ansorgeolaf deeptopographicproteomicsofahumanbraintumour AT fischerroman deeptopographicproteomicsofahumanbraintumour |